Funding for this research was provided by:
Suzhou introduce expert team of clinical medicine (SZYJTD201708)
Suzhou key medicine center (SZZX201505)
Jiangsu Provincial medical innovation team (CXTDB2017013)
Maternal and health care project of Jiangsu Province-assisted reproduction medicine center (FKX201224)
Text and Data Mining valid from 2018-08-09
Received: 1 May 2018
Revised: 26 June 2018
Accepted: 6 July 2018
First Online: 9 August 2018
Ethics approval and consent to participate
: The use of human ovarian granular cells and human peripheral blood mononuclear cells was in accordance with the relevant guidelines and regulations, and the experimental protocols were approved by the Medical Ethics Committee of the Suzhou Hospital Affiliated to Nanjing Medical University (NJMU-2015-014). All of the patients provided written informed consent prior to participation in this study. Our investigation using experimental animals was conducted on the basis of the Nanjing Medical University Animal Center’s specific guidelines and standards.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.